{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T18:00:14Z","timestamp":1788976814708,"version":"build-2803163510"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T00:00:00Z","timestamp":1539561600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81472447"],"award-info":[{"award-number":["81472447"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81672575"],"award-info":[{"award-number":["81672575"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81372853"],"award-info":[{"award-number":["81372853"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81572586"],"award-info":[{"award-number":["81572586"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Liaoning Provincial Climbing Scholars"},{"name":"Liaoning Provincial Science and Technology Program for Oversea Talents"},{"DOI":"10.13039\/501100005047","name":"Provincial Natural Science Foundation of Liaoning","doi-asserted-by":"publisher","award":["2014023002"],"award-info":[{"award-number":["2014023002"]}],"id":[{"id":"10.13039\/501100005047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005047","name":"Provincial Natural Science Foundation of Liaoning","doi-asserted-by":"publisher","award":["2015020316"],"award-info":[{"award-number":["2015020316"]}],"id":[{"id":"10.13039\/501100005047","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Liaoning Provincial Key Basic Research Program for Colleges and Universities","award":["LZ2017002"],"award-info":[{"award-number":["LZ2017002"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.canlet.2018.09.030","type":"journal-article","created":{"date-parts":[[2018,10,10]],"date-time":"2018-10-10T06:32:20Z","timestamp":1539153140000},"page":"54-63","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Inhibition of BTF3 sensitizes luminal breast cancer cells to PI3K\u03b1 inhibition through the transcriptional regulation of ER\u03b1"],"prefix":"10.1016","volume":"440-441","author":[{"given":"Jinlei","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaonan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolin","family":"Sang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyan","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongya","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zundong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijue","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanlin","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzhi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuwen","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pixu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailing","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2018.09.030_bib1","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nature11412","article-title":"Comprehensive molecular portraits of human breast tumours","volume":"490","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2018.09.030_bib2","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1016\/S0140-6736(16)32419-9","article-title":"Advances in the treatment of advanced oestrogen-receptor-positive breast cancer","volume":"389","author":"Turner","year":"2017","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.canlet.2018.09.030_bib3","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/nrc2713","article-title":"Biological determinants of endocrine resistance in breast cancer","volume":"9","author":"Musgrove","year":"2009","journal-title":"Nat. Rev. Canc."},{"key":"10.1016\/j.canlet.2018.09.030_bib4","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrclinonc.2015.117","article-title":"ESR1 mutations-a mechanism for acquired endocrine resistance in breast cancer","volume":"12","author":"Jeselsohn","year":"2015","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.canlet.2018.09.030_bib5","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nrd2926","article-title":"Targeting the phosphoinositide 3-kinase pathway in cancer","volume":"8","author":"Liu","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.canlet.2018.09.030_bib6","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1126\/science.1096502","article-title":"High frequency of mutations of the PIK3CA gene in human cancers","volume":"304","author":"Samuels","year":"2004","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.canlet.2018.09.030_bib7","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2017.72.7107","article-title":"Phosphatidylinositol 3-kinase alpha-selective inhibition with alpelisib (BYL719) in PIK3CA-altered solid tumors: results from the first-in-human study","author":"Juric","year":"2018","journal-title":"J. Clin. Oncol.: Offic. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.canlet.2018.09.030_bib8","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2147\/OTT.S89967","article-title":"PI3K inhibitors as new cancer therapeutics: implications for clinical trial design","volume":"9","author":"Massacesi","year":"2016","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.canlet.2018.09.030_bib9","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1158\/1078-0432.CCR-16-0134","article-title":"A phase Ib study of alpelisib (BYL719), a PI3K\u03b1-specific inhibitor, with letrozole in ER+\/HER2-Negative metastatic breast cancer","volume":"23","author":"Mayer","year":"2017","journal-title":"Clin. Canc. Res.: Offic. J. Am. Assoc. Canc. Res."},{"key":"10.1016\/j.canlet.2018.09.030_bib10","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/nrc3860","article-title":"PI3K in cancer: divergent roles of isoforms, modes of activation and therapeutic targeting","volume":"15","author":"Thorpe","year":"2015","journal-title":"Nat. Rev. Canc."},{"key":"10.1016\/j.canlet.2018.09.030_bib11","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa4442","article-title":"PI3K inhibition results in enhanced estrogen receptor function and dependence in hormone receptor-positive breast cancer","volume":"7","author":"Bosch","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.canlet.2018.09.030_bib12","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1126\/science.aah6893","article-title":"PI3K pathway regulates ER-dependent transcription in breast cancer through the epigenetic regulator KMT2D","volume":"355","author":"Toska","year":"2017","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.canlet.2018.09.030_bib13","doi-asserted-by":"crossref","first-page":"367","DOI":"10.4161\/cbt.6.3.3704","article-title":"Basic transcription factor 3 (BTF3) regulates transcription of tumor-associated genes in pancreatic cancer cells","volume":"6","author":"Kusumawidjaja","year":"2007","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.canlet.2018.09.030_bib14","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1021\/pr0498180","article-title":"Proteomic studies on low- and high-grade human brain astrocytomas","volume":"4","author":"Odreman","year":"2005","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.canlet.2018.09.030_bib15","first-page":"216","article-title":"Construction of a prognostic prediction system for pancreatic ductal adenocarcinoma to investigate the key prognostic genes","volume":"17","author":"Zheng","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.canlet.2018.09.030_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0084295","article-title":"Quantitative analysis of BTF3, HINT1, NDRG1 and ODC1 protein over-expression in human prostate cancer tissue","volume":"8","author":"Symes","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2018.09.030_bib17","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1007\/s13277-013-0745-8","article-title":"Clinicopathological significance of BTF3 expression in colorectal cancer","volume":"34","author":"Wang","year":"2013","journal-title":"Tumour Biol.: J. Int. Soc. Oncodevelopmental Biol. Med."},{"key":"10.1016\/j.canlet.2018.09.030_bib18","doi-asserted-by":"crossref","first-page":"4495","DOI":"10.3748\/wjg.v19.i28.4495","article-title":"Basic transcription factor 3 is involved in gastric cancer development and progression","volume":"19","author":"Liu","year":"2013","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.canlet.2018.09.030_bib19","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1158\/0008-5472.CAN-13-0544","article-title":"A genetic mouse model of invasive endometrial cancer driven by concurrent loss of Pten and Lkb1 Is highly responsive to mTOR inhibition","volume":"74","author":"Cheng","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2018.09.030_bib20","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ygyno.2016.07.092","article-title":"Combined inhibition of PI3K and PARP is effective in the treatment of ovarian cancer cells with wild-type PIK3CA genes","volume":"142","author":"Wang","year":"2016","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.canlet.2018.09.030_bib21","doi-asserted-by":"crossref","first-page":"13153","DOI":"10.18632\/oncotarget.7549","article-title":"Effective use of PI3K inhibitor BKM120 and PARP inhibitor Olaparib to treat PIK3CA mutant ovarian cancer","volume":"7","author":"Wang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2018.09.030_bib22","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.ccr.2008.11.003","article-title":"Akt determines replicative senescence and oxidative or oncogenic premature senescence and sensitizes cells to oxidative apoptosis","volume":"14","author":"Nogueira","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2018.09.030_bib23","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1158\/1078-0432.CCR-06-2765","article-title":"Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series","volume":"13","author":"Desmedt","year":"2007","journal-title":"Clin. Canc. Res.: Offic. J. Am. Assoc. Canc. Res."},{"key":"10.1016\/j.canlet.2018.09.030_bib24","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0140-6736(05)70933-8","article-title":"Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer","volume":"365","author":"Wang","year":"2005","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.canlet.2018.09.030_bib25","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1200\/JCO.2008.18.1370","article-title":"Supervised risk predictor of breast cancer based on intrinsic subtypes","volume":"27","author":"Parker","year":"2009","journal-title":"J. Clin. Oncol.: Offic. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.canlet.2018.09.030_bib26","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000328054","article-title":"St. Gallen 2011: summary of the consensus discussion","volume":"6","author":"Gnant","year":"2011","journal-title":"Breast care (Basel, Switzerland)"},{"key":"10.1016\/j.canlet.2018.09.030_bib27","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1159\/000475698","article-title":"St Gallen\/vienna 2017: a brief summary of the consensus discussion about escalation and de-escalation of primary breast cancer treatment","volume":"12","author":"Gnant","year":"2017","journal-title":"Breast care (Basel, Switzerland)"},{"key":"10.1016\/j.canlet.2018.09.030_bib28","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/334077a0","article-title":"A yeast activity can substitute for the HeLa cell TATA box factor","volume":"334","author":"Cavallini","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2018.09.030_bib29","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/344556a0","article-title":"Sequencing and expression of complementary DNA for the general transcription factor BTF3","volume":"344","author":"Zheng","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2018.09.030_bib30","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0092-8674(87)90490-9","article-title":"A general transcription factor forms a stable complex with RNA polymerase B (II)","volume":"50","author":"Zheng","year":"1987","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2018.09.030_bib31","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/ng1901","article-title":"Genome-wide analysis of estrogen receptor binding sites","volume":"38","author":"Carroll","year":"2006","journal-title":"Nat. Genet."},{"key":"10.1016\/j.canlet.2018.09.030_bib32","doi-asserted-by":"crossref","first-page":"10393","DOI":"10.1073\/pnas.1732912100","article-title":"Breast cancer classification and prognosis based on gene expression profiles from a population-based study","volume":"100","author":"Sotiriou","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.canlet.2018.09.030_bib33","doi-asserted-by":"crossref","first-page":"10992","DOI":"10.1158\/0008-5472.CAN-05-2612","article-title":"Breast cancer-associated PIK3CA mutations are oncogenic in mammary epithelial cells","volume":"65","author":"Isakoff","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2018.09.030_bib34","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nrc3093","article-title":"The different roles of ER subtypes in cancer biology and therapy","volume":"11","author":"Thomas","year":"2011","journal-title":"Nat. Rev. Canc."},{"key":"10.1016\/j.canlet.2018.09.030_bib35","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1158\/1541-7786.MCR-07-0123","article-title":"Interaction between transcription factor, basal transcription factor 3, and the NH2-terminal domain of human estrogen receptor alpha","volume":"5","author":"Green","year":"2007","journal-title":"Mol. Canc. Res.: MCR"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383518306050?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383518306050?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T15:01:13Z","timestamp":1605193273000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383518306050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":35,"alternative-id":["S0304383518306050"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2018.09.030","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of BTF3 sensitizes luminal breast cancer cells to PI3K\u03b1 inhibition through the transcriptional regulation of ER\u03b1","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2018.09.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Second Hospital of Dalian Medical University, Dalian Medical University. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}